HealthEquity (HQY) Earnings Date & Reports

Key Takeaways

• Revenue rose 7% year-over-year to $354.6 million, slightly above consensus estimates of approximately $354.4 million.
• Non-GAAP earnings per share came in at $1.24, beating analyst expectations of $1.11 by roughly 11.7%.
• Adjusted EBITDA margin expanded to 46%, up from 42% in the prior-year quarter, reflecting improved operating leverage and AI-driven cost efficiencies.
• Total HSA assets grew 19% year-over-year to $37.1 billion, with invested HSA assets surging 38%.
• Full-year fiscal 2027 guidance was raised on both the top and bottom line, and the board authorized an additional $1 billion in share repurchases.

Earnings Context and Why It Matters

HealthEquity (NASDAQ: HQY), the largest independent health savings account (HSA) custodian in the United States by account volume, reported results for the first quarter of fiscal 2027 (ended April 30, 2026) on May 28, 2026. This earnings report carries significant weight for investors because it marks the start of a new fiscal year and arrives at a time when the company is demonstrating accelerating operating leverage. After several quarters of steady margin improvement, the first-quarter results confirmed that HealthEquity's investments in artificial intelligence, digital engagement, and its Marketplace platform are translating into tangible financial gains. The combination of rising HSA adoption, growing invested assets, and technology-enabled cost control makes this earnings release an important barometer for the company's long-term compounding model.

Reported Results

HealthEquity posted total revenue of $354.6 million for the first quarter of fiscal 2027, a 7% increase compared to $330.8 million in the same period last year. The top-line figure edged past the consensus analyst estimate of approximately $354.4 million. Revenue growth was driven primarily by custodial revenue, which climbed 11% year-over-year to a record $174.3 million, fueled by higher average yields on HSA cash and a growing base of members enrolled in enhanced-rate programs. Service revenue reached a record $122.9 million (up 3%), supported by Marketplace activity and account growth, while interchange revenue grew 5% to $57.4 million.

On the bottom line, GAAP net income jumped 29% to $69.4 million, or $0.82 per diluted share, compared to $53.9 million, or $0.61 per diluted share, in the prior-year quarter. Non-GAAP net income, which excludes amortization of acquired intangible assets and stock-based compensation, rose 22% to $105.1 million, or $1.24 per diluted share. This comfortably exceeded the analyst consensus estimate of $1.11 per share. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 17% to $164.5 million, with the Adjusted EBITDA margin expanding 400 basis points to 46%, a new quarterly record for the company.

Gross margin expanded to 72.3%, up from 68% a year earlier, reflecting lower fraud-related service costs—fraud reimbursements fell from $3.2 million to just $0.3 million—as well as AI-enabled automation that reduced manual handling of service emails by 25% and cut card-servicing inquiries by over 90% in targeted workflows. Account metrics were equally robust: total HSAs reached 10.6 million (up 8%), while total HSA assets grew 19% to $37.1 billion, powered by a 38% surge in invested HSA assets to $19.6 billion.

AI Screener

Investors seeking to identify opportunities similar to HealthEquity or to scan the broader market for stocks displaying strong earnings momentum can leverage Tickeron's AI Screener. This AI-powered stock and ETF discovery tool allows traders and investors to filter thousands of securities using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and AI-driven signals. Whether you are looking for breakout candidates, trending stocks, or fundamentally sound companies with improving margins, the AI Screener can help surface relevant trade ideas far more efficiently than manual screening. Explore the tool to see what opportunities the market may be presenting right now.

Market Reaction and Investor Sentiment

The market responded favorably to HealthEquity's first-quarter results. Shares rose approximately 4.6% during regular trading on the day of the announcement, with an additional gain of about 1% in the after-hours session. The positive reaction reflected broad investor approval of the earnings beat, margin expansion, and the raised full-year guidance. The $1 billion increase in the share repurchase authorization also signaled management's conviction that the stock remains undervalued relative to the company's durable revenue growth and expanding profitability. Heading into the report, investor sentiment had been cautiously optimistic, with analysts expecting continued sequential improvement. The magnitude of the margin expansion, however, appeared to catch many by surprise, reinforcing the narrative that AI-driven operational efficiencies are compounding faster than anticipated.

Forward Outlook and Key Factors to Monitor

Looking ahead, HealthEquity's raised fiscal 2027 guidance provides a clearer roadmap for what investors can expect. Management now projects full-year revenue between $1.410 billion and $1.420 billion, non-GAAP net income of $392 million to $398 million ($4.66 to $4.73 per share), and Adjusted EBITDA between $625 million and $633 million. These figures assume continued momentum in account and asset growth, ongoing adoption of enhanced-rate HSA cash programs, and sustained benefits from AI-driven automation.

Several factors deserve close attention in the quarters ahead. First, the trajectory of interest rates and the company's custodial cash yield—which averaged 3.84% in Q1, helped in part by a one-time depository breakage fee—will influence custodial revenue. HealthEquity has hedged approximately $3.5 billion in maturing HSA cash contracts through fiscal 2029 using forward Treasury contracts that lock in five-year rates near 3.9%, reducing near-term repricing risk but leaving some exposure to rate movements beyond the hedged window.

Second, the company's Marketplace initiative is still in its early stages but showing promising traction. With over 10,000 members now accessing health-related programs and products, and newer categories such as diagnostics and men's health recently added, Marketplace could become a more meaningful contributor to revenue and member lifetime value over time.

Third, the competitive landscape in HSA administration remains dynamic. HealthEquity's ability to continue outpacing the broader industry growth rate—total HSA accounts grew 8% versus the industry's estimated 6%—will be a key test of its platform advantage. Finally, investors should monitor medical claims utilization trends, which were lower than expected in Q1 and contributed modestly to the margin beat, but could normalize in future periods.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations